Reports for TAKEDA CANADA INC

Company Name

TAKEDA CANADA INC

Totals

Shortage reports

52
Actual shortage: 1 (2%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 51 (98%)

Discontinuation Reports

7
To be discontinued: 0 (0%)
Discontinued: 7 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OBIZUR 500UNIT POWDER FOR SOLUTION Resolved 2020-07-30 2020-08-18 121439
VYVANSE 70MG CAPSULE Resolved 2018-06-04 2018-06-13 51253
RIXUBIS 1000UNIT POWDER FOR SOLUTION KIT Resolved 2021-07-07 2021-08-26 141947
RIXUBIS 1000UNIT POWDER FOR SOLUTION KIT Resolved 2023-07-13 2023-08-28 198631
RIXUBIS 2000UNIT POWDER FOR SOLUTION KIT Resolved 2023-07-13 2023-08-28 198627
CUVITRU 200MG SOLUTION Resolved 2019-04-29 2019-08-24 82602
TAKHZYRO 300MG SOLUTION Resolved 2021-12-15 2022-01-13 151175
RIXUBIS 3000UNIT POWDER FOR SOLUTION KIT Resolved 2023-07-13 2023-08-28 198634
VYVANSE 10MG TABLET (CHEWABLE) Resolved 2021-12-02 2021-12-12 150423
VYVANSE 40MG TABLET (CHEWABLE) Resolved 2023-02-24 2023-03-07 185609
ADYNOVATE 250UNIT POWDER FOR SOLUTION KIT Resolved 2022-06-30 2022-09-22 163980
ADYNOVATE 3000UNIT KIT POWDER FOR SOLUTION Resolved 2020-11-13 2021-01-06 128401

Showing 41 to 52 of 52

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
AGRYLIN 0.5MG CAPSULE Discontinued 2023-11-15 2024-03-01 210182
PANTO IV 40MG POWDER FOR SOLUTION Discontinued 2017-03-15 2017-03-15 2969
ACTOS 15MG TABLET Discontinued 2018-04-02 2018-04-02 44428
ACTOS 30MG TABLET Discontinued 2018-04-02 2018-04-02 44433
ACTOS 45MG TABLET Discontinued 2018-04-02 2018-04-02 44438
FOSRENOL 250MG TABLET (CHEWABLE) Discontinued 2022-12-20 2023-04-30 178916
ULORIC 80MG TABLET Discontinued 2021-08-17 2022-01-04 144266

Showing 1 to 7 of 7